Introduction to Antifungal Drugs
Open Access
- 1 April 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (4), 653-657
- https://doi.org/10.1086/313748
Abstract
In the United States, only 10 antifungal drugs are currently approved by the Food and Drug Administration (FDA) for the therapy of systemic fungal infections. AKeywords
This publication has 22 references indexed in Scilit:
- Systemic Antifungal AgentsDrug Safety, 1998
- Overview of Oral Azole Drugs as Systemic Antifungal TherapySeminars in Respiratory and Critical Care Medicine, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Lipid Formulations of Amphotericin B: Recent Progress and Future DirectionsClinical Infectious Diseases, 1996
- FluconazoleDrugs, 1995
- Pretreatment Regimens for Adverse Events Related to Infusion of Amphotericin BClinical Infectious Diseases, 1995
- Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal TherapyClinical Infectious Diseases, 1992
- FluconazoleDrugs, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- ItraconazoleDrugs, 1989